Nationally, nongroup marketplace premiums are 10% lower than the average employer-sponsored insurance premiums, according to an analysis by the Urban Institute.
Nationally, nongroup marketplace premiums are 10% lower than the average employer-sponsored insurance premiums, according to an analysis by the Urban Institute. In addition, the research found that more than three-fourths of states and more than 80% of metropolitan areas have lower marketplace than employer premiums.
The study, by Linda J. Blumberg, John Holahan, and Erik Wengle, compared unsubsidized 2016 nongroup marketplace premiums to the average employer-sponsored insurance premiums in all 50 states and 73 metropolitan areas.
The study was undertaken to examine news accounts in recent months that have pointed to large increases in marketplace premiums throughout much of the nation.
“Many have taken these reports to question the viability of the marketplaces and the Affordable Care Act (ACA) in general,” the authors noted.
The focus of criticism is that the full, unsubsidized premiums available in the marketplace are high because the pool of nongroup insured are sicker than expected, and that it is proof that the new markets do not work. People with incomes above 400% of the federal poverty level bear the full premiums, and the higher the unsubsidized premiums, the higher the federal government’s costs for the premium tax credits.
The study authors compared nongroup premiums with employer premiums, because employer coverage has long been considered a natural risk-pooling mechanism and approximately 100 million workers plus their dependents were enrolled in employer plans in 2014. As a result, employer-sponsored plans are more likely to reflect average costs for a broad representation of the population, and likely enjoy a more efficient market in which to purchase insurance, the authors wrote.
The study found that:
“With few exceptions, the level and growth of nongroup premiums in the Marketplaces should not be interpreted as evidence that these new markets are weak,” the authors concluded. “Nongroup insurance, when adjusted to make its premiums comparable to employer premiums, is much more often than not lower cost than the average coverage offered through employers.”
The persistent, uncomfortable truth is that healthcare is an expensive commodity, regardless of the market in which one purchases it.
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Integrated CKD Care Model Cuts ED Visits by 30%, Boosts Specialized Treatment
April 21st 2025An analysis of an interdisciplinary care model for managing chronic kidney disease (CKD) shows hospital admissions dropped by 26% and emergency department (ED) visits decreased by 30% after clinic initiation.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Integrated CKD Care Model Cuts ED Visits by 30%, Boosts Specialized Treatment
April 21st 2025An analysis of an interdisciplinary care model for managing chronic kidney disease (CKD) shows hospital admissions dropped by 26% and emergency department (ED) visits decreased by 30% after clinic initiation.
Read More
2 Commerce Drive
Cranbury, NJ 08512